New drug Dostarlimab cures all patients in trial 'first time in history

A small clinical trial discovered that every single rectal cancer patient who got an experimental treatment saw their disease vanish, in what looks to be a miracle and a "first in history". According to the New York Times, 18 patients took a medicine named Dostarlimab for six months in a limited clinical trial done by Memorial Sloan Kettering Cancer Center, and all of them saw their tumours shrink at the end. Experts stated that the malignancy is undetectable by physical examination, endoscopy, positron emission tomography or PET scans, or MRI scans. This shows that Dostarlimab has the potential to be a 'possible' cancer cure for one of the most lethal tumours.

For Further Info:-https://bit.ly/3mpHiT4




Comments

Post a Comment

Popular posts from this blog

Neurodegenerative Disorder Therapeutics Market - Improvement in the healthcare infrastructure is likely to create new opportunity for the market

Image
Neurodegenerative Disorder Therapeutics Market   accounted for US$ 9.32 billion in 2019 and is estimated to be US$ 21.3 billion by 2029 and is anticipated to register a CAGR of 8.7% The report " Global  Neurodegenerative Disorder Therapeutics Market, By  Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, and Other Drug Types), By Distribution (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In November 2019, Alkermes plc and Rodin Therapeutics, Inc. announced that they have entered into a definitive agreement under which Alkermes will acquire Rodin, a privately held biopharmaceutical company focused ...
Read more

Systemic Lupus Erythematosus Market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%

Image
  Systemic Lupus Erythematosus (SLE) is the chronic, autoimmune disorder which involves several organ-systems such as kidney, heart, blood, skin, joints, and lungs in most severe cases, brain. In this disease, the human immune system converts hyperactive and attacks the healthy, normal tissues of the body. SLE can often result in symptoms such as malar rash, sub-acute cutaneous lesions, discoid lesions, arthritis, photosensitivity, oral ulcers, serositis, nephropathy, thrombocytopenia, haemolytic anemia, neurologic involvement, fever, thrombosis, Raynaud’s phenomenon, livedo reticularis, and myositis. The global systemic lupus erythematosus market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%. The report  " Global   Systemic Lupus Erythematosus Market, By Drug Classes (NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, and Biologics), By Route of Administration (Oral, In...
Read more

Veterinary Orthopedic Implants Market is estimated to be 421.3 Million by 2029 with a CAGR of 5.3% during the forecasted period.

Image
  Veterinary Orthopedic Implants Market is anticipated to register a CAGR of 12.6% during the forecasted period.Orthopedic implants are used to treat various orthopedic conditions like healing broken bones and joints. With a growing number of people owning companion animals the demand for the veterinary market is growing rapidly. People are willing to spend more on the health of their pets which is strengthening the demand for products used for the health and well-being of the animals. Pet animals like dogs and cats usually suffer from fractures due to vehicular trauma, fights and sports injuries. Even though injuries in animals heal quickly, in case of broken bones orthopedic surgeries are required for healing the bones. Depending on the type of fracture vets decide on the treatment type and implants. With growing approvals for the orthopedic implants for animals, the veterinary orthopedic implants market is expected to witness attractive opportunities over the forecast period. ...
Read more